Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03237091 · ClinicalTrials.gov registry record · NA

Enhancing Corticospinal Excitability to Improve Functional Recovery

A NA study, sponsored by Shepherd Center, Atlanta GA.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT03237091 is a NA study that has completed, run by Shepherd Center, Atlanta GA. The registered enrollment target is 19 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03237091, a NA study, has completed, sponsored by Shepherd Center, Atlanta GA.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

Research indicates that increasing brain excitability might help improve hand function in people with spinal cord injury. Brain stimulation that uses electrodes placed on the surface of the scalp (also called "non-invasive brain stimulation") increases brain excitability and has the potential to make it easier for the brain and nervous system to respond to arm and hand training. The purpose of this study is to compare four different types of stimulation for increasing brain excitability to determine which types are best for helping people with tetraplegia improve their ability to use their arms and hands. To fully evaluate the value of brain stimulation on arm and hand function, the investigators will also evaluate the effect of sham (fake) stimulation. Each participant will receive a single session of each of the five types of stimulation being tested.

Interventions

  • OTHER bihemispheric transcranial pulsed current stimulation (tPCS)
  • OTHER unihemispheric transcranial pulsed current stimulation (tPCS)
  • OTHER bihemispheric transcranial direct current stimulation (tDCS)
  • OTHER unihemispheric transcranial direct current stimulation (tDCS)
  • OTHER sham-control

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2018-05-03
Est. Completion 2019-09-27
Phase NA

Sponsor

Shepherd Center, Atlanta GA

17 total trials

What the Registry Record Tells You About NCT03237091

The ClinicalTrials.gov registry entry for NCT03237091 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shepherd Center, Atlanta GA, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which bihemispheric transcranial pulsed current stimulation (tPCS) is the first listed.

NCT03237091 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03237091 about?

NCT03237091 is a clinical study titled "Enhancing Corticospinal Excitability to Improve Functional Recovery". Research indicates that increasing brain excitability might help improve hand function in people with spinal cord injury. Brain stimulation that uses electrodes placed on the surface of the scalp (also called "non-invasive brain stimulation") increases brain excitability and has the potential to mak...

What is the current status of trial NCT03237091?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-05-03. Estimated completion is 2019-09-27.

What interventions are being tested in trial NCT03237091?

The interventions under investigation include: bihemispheric transcranial pulsed current stimulation (tPCS) (OTHER), unihemispheric transcranial pulsed current stimulation (tPCS) (OTHER), bihemispheric transcranial direct current stimulation (tDCS) (OTHER), unihemispheric transcranial direct current stimulation (tDCS) (OTHER), sham-control (OTHER).

Who is sponsoring clinical trial NCT03237091?

This trial is sponsored by Shepherd Center, Atlanta GA, which has 17 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.